The regulatory imperative: International perspective

Tissue Engineering - Part B: Reviews

Volumn 19, Issue 3, 2013, Pages 191-193

  Bertram, Tim ^a   Hellman, Kiki B ^b   Bayon, Yves ^c   Ellison, Simon ^d   Wilburn, Sarah ^e  

^a Tengion Inc   (United States)

^b Hellman Group   (United States)

^c MEDTRONIC INC   (United States)

^d NHS BLOOD AND TRANSPLANT   (United Kingdom)

^e Tissue Engineering and Regenerative Medicine International Society Inc (TERMIS)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; FOOD AND DRUG ADMINISTRATION; LAW; MEDICAL DEVICE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION;

HUMANS; INTERNATIONALITY; REGENERATIVE MEDICINE; SOCIAL CONTROL, FORMAL; TISSUE ENGINEERING;

EID: 84876259287     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2012.0654     Document Type: Review

References (11)

1. Johnson, P.C., Bertram, T.A., Tawil, B., and Hellman, K.B. Hurdles in tissue engineering/regenerative medicine product commercialization: a survey of North American academia and industry. Tissue Eng Part A 17, 5, 2011.
2. Hellman, K.B., Johnson, P.C., Bertram, T.A., and Tawil, B. Challenges in tissue engineering and regenerative medicine product commercialization: building an industry. Tissue Eng Part A 17, 1, 2011.
3. Bertram, T.A., Tentoff, E., Johnson, P.C., Tawil, B., Van Dyke, M., and Hellman, K.B. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry. Tissue Eng Part A 18, 2187, 2012.
4. Lysaght, M.J., Jaklenec,A., and Deweerd, E.Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A 14, 305, 2008.
5. Lysaght, M.J., and Hazlehurst, A.L. Tissue engineering: the end of the beginning. Tissue Eng 10, 309, 2004.
6. Lysaght, M.J., and Hazlehurst, A.L. Private sector development of stem cell technology and therapeutic cloning. Tissue Eng 9, 555, 2003.
7. Lysaght, M.J., and Reyes, J. The growth of tissue engineering. Tissue Eng 7, 485, 2001.
8. Lysaght, M.J., Nguy, N.A., and SulliVan, K. An economic survey of the emerging tissue engineering industry. Tissue Eng 4, 23, 1998.
9. Lysaght, M.J. Product development in tissue engineering. Tissue Eng 1, 221, 1995.
10. Johnson, P.C., Mikos, A.G., Fisher, J.P., and Jansen, J.A. Strategic directions in tissue engineering. Tissue Eng 13, 2827, 2007.
11. TERMIS-AM Industry Committee. http://www.termis.org/chapters-am- committees.phpc=industry.